Provided by Tiger Fintech (Singapore) Pte. Ltd.

MannKind

4.61
+0.535013.14%
Volume:6.23M
Turnover:27.96M
Market Cap:1.41B
PE:42.56
High:4.62
Open:4.17
Low:4.17
Close:4.07
52wk High:7.63
52wk Low:3.38
Shares:306.83M
Float Shares:300.98M
Volume Ratio:2.84
T/O Rate:2.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1082
EPS(LYR):0.1005
ROE:32.74%
ROA:10.63%
PB:-25.67
PE(LYR):45.81

Loading ...

Stock Track | MannKind Plunges 6.02% Pre-market Despite Q2 Profits and $500M Blackstone Deal

Stock Track
·
Aug 06

Stock Track | MannKind Shares Plunge 6.02% Pre-market Despite Q2 Results and $500 Million Blackstone Deal

Stock Track
·
Aug 06

Biotech firm MannKind's Q2 revenue rises 6%

Reuters
·
Aug 06

MannKind Q2 Revenue $76.5 Million

THOMSON REUTERS
·
Aug 06

MannKind Q2 Operating Income USD 5.299 Million

Reuters
·
Aug 06

Stock Track | MannKind Soars 6.02% Pre-market on Strong Q2 Results and $500 Million Blackstone Deal

Stock Track
·
Aug 06

MannKind Corporation Reports 6% Increase in Q2 2025 Revenues to $76.5M, Net Income of $0.7M, EPS $0.00

Reuters
·
Aug 06

MannKind Corp - Facility Matures in August 2030

THOMSON REUTERS
·
Aug 06

MannKind Corp - to Receive $75 Mln in Cash at Closing

THOMSON REUTERS
·
Aug 06

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

GlobeNewswire
·
Aug 06

MannKind Q2 Basic EPS USD 0

THOMSON REUTERS
·
Aug 06

MannKind Q2 Net Income USD 668 Thousand

THOMSON REUTERS
·
Aug 06

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

GlobeNewswire
·
Aug 06

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

GlobeNewswire
·
Jul 31

MannKind’s Growth Potential Bolstered by United Therapeutics Partnership and Promising Pipeline

TIPRANKS
·
Jul 31

RBC Cuts Price Target on MannKind to $8 From $10, Keeps Outperform Rating

MT Newswires Live
·
Jul 23

Steven B. Binder, Director, Reports Disposal of Common Shares of MannKind Corporation

Reuters
·
Jul 18

David Thomson, EVP Genl Counsel & Secretary, Reports Disposal of MannKind Corporation Common Shares

Reuters
·
Jul 18

MannKind assumed with a Buy at H.C. Wainwright

TIPRANKS
·
Jul 16

MannKind’s Afrezza: A Promising Undervalued Opportunity in Diabetes Treatment

TIPRANKS
·
Jun 27